ePosters
Spinal Cord Stimulation (SCS) is an effective therapy for chronic pain, with its long-term efficacy well-established. However, some may experience loss-of-efficacy (LoE) over time and become refractory over course of follow-up.1-2 To avoid explantation, these patients may undergo a "conversion" to a different SCS system with advanced programming capabilities allowing customized delivery of analgesic neurostimulation.3-4 We assessed a cohort of previously-implanted patients who converted to an SCS device capable of multiple paresthesia-based and sub-perception waveforms.
Philippe Rigoard, MD
Neurosurgeon
CHU de Poitiers, United States
Renaud Bougeard, MD
Pain Management Physician
Clinique de la Sauvegarde, United States
Jose Emilio Llopis-Calatayud, MD
Professor
Hospital de la Ribera, United States
Sylvie Raoul, MD, PhD
Professor
Nantes University Hospital, United States
Georgios Matis, MD
Neurosurgeon
University Hospital Cologne, United States
Hayat Belaid, MD
Neurosurgeon
Fondation Adolphe de Rothschild, United States
Jan Vesper, MD, PhD
Professor
University of Düsseldorf, United States
M. Angeles Canos-Verdecho, MD
Professor
University and Polytechnic Hospital La Fe, United States
Sarah Love-Jones, MD
Pain Management Physician
Southmead Hospital, United States
Adam Williams, MD
Neurosurgeon
Southmead Hospital, United States
Edward Goldberg, MD
Director, Clinical Research
Boston Scientific
Valencia, California, United States